Supriya Lifescience Ltd

  • BSE Code : 543434
  • NSE Symbol : SUPRIYA
  • ISIN : INE07RO01027
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 711.30 -9.00(-1.25%)

Open Price ()

720.30

Prev. Close ()

720.30

Volume (No’s)

99,144

Market Cap ()

5,724.74

Low Price ()

710.00

High Price ()

725.00

 

Corporate Announcement

18-Jul-2025 Supriya Lifescience Limited - Analysts/Institutional Investor Meet/Con. Call Updates
11-Jul-2025 Supriya Lifescience Limited - Certificate from Debenture Trustee
09-Jul-2025 Supriya Lifescience Limited - Reply to Clarification- Financial results
08-Jul-2025 Supriya Lifescience Limited - Reply to Clarification- Financial results
04-Jul-2025 Supriya Lifescience Limited - Disclosure under SEBI Takeover Regulations

Stock Summary

Market Cap(₹Cr.)

5,807.24

P/E (TTM)

30.9

Book value ()

123.85

Div Yield (%)

0.14

EPS (TTM)

23.35

Face Value ()

2.00

Technical Analysis

Key Level

Resistance 1

725.55

Resistance 2

730.80

Support 1

715.90

Support 2

711.50

Moving Average

30 Days

697.75

50 Days

702.58

100 Days

688.85

200 Days

684.33

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Supriya Lifescience Ltd 5,725.55 30.47 3.27 186.65 0.14 23.35
Sun Pharmaceutical Indust.. 406,267.39 95.02 17.11 7162.05 0.94 17.82
Divis Laboratories Ltd 178,672.30 80.91 10.27 3332 0.44 83.18
Cipla Ltd 119,712.77 24.87 3.63 7057.82 1.08 59.59
Torrent Pharmaceuticals L.. 119,190.05 62.99 14.42 3583.06 0.17 55.91

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of Returns(%)

in Months Ago

My investment would be worth with a Loss of

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 6753836 8.39
Total Institutions 3427120 4.26
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 1205807 1.50
Total Promoters 54967825 68.30
Total Public & others 14128212 17.55
Total 80482800 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'. The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007. Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai.

The Company commenced operations in April, 2008. It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs). The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development. The company have niche product offerings of 39 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. The company have consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-55% and 65-70%, respectively,of the API exports from India, between Fiscal 2017 and 2020.

The company is among the largest exporters of Salbutamol Sulphate from India in Fiscal 2020 in terms of volume.The company's produ...

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew